サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Global Spine Biologics Market Forecast 2016-2026

世界の脊椎生物製剤市場予測2016-2026

レポート概要

世界の脊椎生物製剤市場は、予測期間中に一桁台の伸び率で拡大することが予想されます。2015年における市場規模は29億9,700万ドルでした。Visiongainは2020年には38億9,900万ドルに達すると予想しています。その後も拡大が続き2020-2026年のCAGRは6.2%、2026年には56億400万ドルに達する見込みです。

このレポートを利用することによってどのようなメリットがあるでしょうか。
このセクターで新たに出現しているビジネスチャンスを見極めることができます。

この142ページのレポートには125の詳細なグラフを掲載 - これらは全て他のどこにも見られません。世界の脊椎生物製剤市場について明確で詳細な洞察を得ることができます。市場に影響を及ぼす主な推進要因と課題が見つかります。

レポートの範囲
- 米国
- カナダ
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他のヨーロッパ
- 日本
- 中国
- インド
- オーストラリア
- その他のアジア太平洋
- その他

レポート詳細

目次

Table of Contents

1. Report Overview
1.1 Global Spine Biologics Market Overview
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Who is This Report For?
1.5 Methodology
1.5.1 Primary Research
1.5.2 Secondary Research
1.5.3 Market Evaluation & Forecasting Methodology
1.6 Frequently Asked Questions (FAQ)
1.7 Associated Visiongain Reports
1.8 About Visiongain

2. Introduction to the Global Spine Biologics Market
2.1 Global Spine Biologics Market Structure
2.2 Spine Biologics Market Definition
2.3 Spine Biologics Submarkets Definition
2.3.1 Demineralized Bone Matrix Submarket Definition
2.3.2 BMP/Growth Factors Submarket Definition
2.3.3 Bone Substitutes Submarket Definition
2.3.4 Cell Based Matrices Submarket Definition
2.3.5 Machined Bones Submarket Definition
2.3.6 Allograft Bones Submarket Definition
2.4 Regulations for Biologics

3. Global Spine Biologics Market 2016-2026
3.1 Global Spine Biologics Market Forecast 2016-2026
3.2 Global Spine Biologics Drivers & Restraints 2016

4. Spine Biologics Market by Product 2016-2026
4.1 Introduction
4.2 Demineralized Bone Matrix (DBM) Market 2016-2026
4.3 BMP/Growth Factors Market 2016-2026
4.4 Bone Substitutes Market 2016-2026
4.5 Cell Based Matrices Market 2016-2026
4.6 Machined Bone Market 2016-2026
4.7 Allograft Bone Market 2016-2026
4.8 Platelet Concentrators Market 2016-2026
4.9 Other Spine Biologics Market 2016-2026

5. Spine Biologics Market by Type of Surgery 2016-2026
5.1 Introduction
5.2 Traditional Fusion Market 2016-2026
5.3 Interbody Fusion Market 2016-2026

6. Spine Biologics Market by End Users 2016-2026
6.1 Introduction
6.2 Inpatient Surgery Spine Centers 2016-2026
6.3 Outpatient Surgery Spine Centers 2016-2026

7. Leading National Markets 2016-2026
7.1 Introduction
7.2 North America Spine Biologics Market 2016-2026
7.2.1 U.S. Spine Biologics Market 2016-2026
7.2.2 Canada Spine Biologics Market 2016-2026
7.3 Europe Spine Biologics Market 2016-2026
7.3.1 Germany Spine Biologics Market 2016-2026
7.3.2 U.K. Spine Biologics Market 2016-2026
7.3.3 France Spine Biologics Market 2016-2026
7.3.4 Italy Spine Biologics Market 2016-2026
7.3.5 Spain Spine Biologics Market 2016-2026
7.3.6 Russia Spine Biologics Market 2016-2026
7.3.7 Rest of Europe Spine Biologics Market 2016-2026
7.4 Asia-Pacific Spine Biologics Market 2016-2026
7.4.1 Japan Spine Biologics Market 2016-2026
7.4.2 China Spine Biologics Market 2016-2026
7.4.3 India Spine Biologics Market 2016-2026
7.4.4 Australia Spine Biologics Market 2016-2026
7.4.5 Rest of Asia-Pacific Spine Biologics Market 2016-2026
7.5 Rest of the World (RoW) Spine Biologics Market 2016-2026

8. Leading Companies in the Spine Biologics Market, 2016-2026
8.1 Spine Biologics:
8.2 Medtronic plc
8.2.1 Medtronic Product Portfolio, 2015
8.2.2 Medtronic plc: Historical and Performance Analysis
8.2.3 Medtronic plc: Recent Developments
8.2.3.1 U.S. FDA Approval - Infuse Bone Graft
8.2.3.2 Acquistion of Osteotech Inc.
8.3 SeaSpine Holdings Corporation
8.3.1 SeaSpine Product Portfolio, 2015
8.3.2 SeaSpine: Historical and Performance Analysis
8.3.3 SeaSpine Holdings Corporation: Recent Developments
8.4 DePuy Synthes (a business segment of Johnson & Johnson)
8.4.1 DePuy Synthes: Product Portfolio, 2015
8.4.2 JOHNSON & JOHNSON: Historical and Performance Analysis
8.4.3 DePuy Synthes: Recent Developments
8.4.3.1 Introduction of VIVIGEN CELLULAR BONE MATRIX
8.4.3.2 Agreement with LifeNet Health (U.S.)
8.4.3.3 Launched New Tissue Implant-CONFORM SHEET
8.5 Stryker Corporation
8.5.1 Stryker Corporation Product Portfolio, 2015
8.5.2 Stryker Corporation: Historical and Performance Analysis
8.5.3 Stryker Corporation: Recent Developments
8.5.3.1 Introduction of Next Generation Viable Bone Matrix
8.5.3.2 Strategic Partnership with Osiris
8.5.3.3 Accellos’ Warehouse Management System
8.5.3.4 Acqusition of Orthovita Inc
8.6 GLOBUS MEDICAL, INC.
8.6.1 GLOBUS MEDICAL, INC.Product Portfolio, 2015
8.6.2 GLOBUS MEDICAL, INC.: Historical and Performance Analysis
8.6.3 GLOBUS MEDICAL, INC.: Recent Developments
8.6.3.1 Acquistion of Alphatec’s International Business
8.6.3.2 Acquistion of Transplant Technologies of Texas, Ltd. (TTOT)
8.7 Zimmer Biomet Holdings, Inc.
8.7.1 Zimmer Biomet Holdings, Inc.Product Portfolio, 2015
8.7.2 Zimmer Biomet Holdings, Inc.: Historical and Performance Analysis
8.7.3 Zimmer Biomet Holdings, Inc.: Recent Developments
8.7.3.1 Distribution Agreement with CelgenTek Innovations Corporation
8.7.3.2 Acquistion Biomet, Inc.
8.8 NuVasive, Inc.
8.8.1 NuVasive Inc.Product Portfolio, 2015
8.8.2 NuVasive, Inc.: Historical and Performance Analysis
8.8.3 NuVasive, Inc.: Recent Developments
8.8.3.1 Launch of Next Generation Biologics Technology
8.9 Alphatec Holdings, Inc.
8.9.1 Alphatec Holdings, Inc..Product Portfolio, 2015
8.9.2 Alphatec Holdings, Inc.: Historical and Performance Analysis
8.9.3 Alphatec Holdings, Inc.: Recent Developments
8.9.3.1 Launch of Neocore(TM) Osteoconductive Matrix

9. SWOT Analysis of the Spine Biologics Market
9.1 Strengths
9.1.1 Evolving Regulatory Framework
9.1.2 Technological Innovations in Biomaterials
9.1.3 Initiatives and Supports from the Governments
9.2 Weaknesses
9.2.1 The High Cost of Spine Biologics Products
9.2.2 Lack of Funding from Venture Capital
9.2.3 Lack of Standardisation in Manufacturing Process
9.2.4 New Business Models are yet to be Established
9.3 Opportunities
9.3.1 Development of 3D Printed Bone Grafts and Other Innovative Technology
9.3.2 Rising Trend of Medical Tourism in Emerging Countries
9.3.3 Growing Number of Spine Surgery Centers and Hospitals
9.4 Threats
9.4.1 Ethical Concerns Limiting Research and Development in Spine Biologics
9.4.2 Scarcity of Skilled Physicians in Emerging Countries

10. Conclusions and Recommendations
10.1 Overview of the Spine Biologics Market
10.2 Leading Spine Biologics Segments in 2016 and 2026
10.2 Leading Spine Biologics Market by Region in 2016 and 2026
10.3 Future Outlook for Spine Biologics Market

Visiongain Report Evaluation Form
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain Report Evaluation Form

List of Tables
Table 1.1 (Sample) Global Spine Biologics Market by Region: Market Forecast ($m), AGR (%), CAGR (%), 2014-2020
Table 3.1 Global Spine Biologics Market Forecast ($m), AGR(%),CAGR(%), 2014-2020
Table 3.2 Global Spine Biologics Market Forecast ($m), AGR(%),CAGR(%), 2020-2026
Table 3.3 Global Spine Biologics Market Drivers & Restraints, 2016
Table 4.1 DBM Market Forecast ($m), AGR(%),CAGR(%), 2016-2026
Table 4.2 BMP/Growth Factors Market Forecast ($m), AGR(%),CAGR(%), 2016-2026
Table 4.3 Bone Substitutes Market Forecast ($m), AGR(%),CAGR(%), 2016-2026
Table 4.4 Cell Based Matrices Market Forecast ($m), AGR(%),CAGR(%), 2016-2026
Table 4.5 Machined Bone Market Forecast ($m), AGR(%),CAGR(%), 2016-2026
Table 4.6 Allograft Bone Market Forecast ($m), AGR(%),CAGR(%), 2016-2026
Table 4.7 Platelet Concentrators Market Forecast ($m), AGR(%),CAGR(%), 2016-2026
Table 4.8 Other Spine Biologics Market Forecast ($m), AGR(%),CAGR(%), 2016-2026
Table 5.1 Spine Biologics Market by Type of Surgery: Market Forecast ($m), AGR(%),CAGR(%), 2014-2020
Table 5.2 Spine Biologics Market by Type of Surgery: Market Forecast ($m), AGR(%),CAGR(%), 2020-2026
Table 5.3 Traditional Fusion Market Forecast ($m), AGR(%),CAGR(%), 2016-2026
Table 5.4 Interbody Fusion Market Forecast ($m), AGR(%), CAGR(%), 2016-2026
Table 6.1 Spine Biologics Market by End User: Market Forecast ($m), AGR(%), CAGR(%), 2014-2020
Table 6.2 Spine Biologics Market by End User: Market Forecast ($m), AGR(%), CAGR(%), 2020-2026
Table 6.3 Inpatient Surgery Spine Centers Market Forecast ($m), AGR(%), CAGR(%), 2016-2026
Table 6.4 Outpatient Surgery Spine Centers Market Forecast ($m), AGR(%), CAGR(%), 2016-2026
Table 7.1 World Spine Biologics Market by Region: Revenues ($m) and Market Share (%), 2015 and 2016
Table 7.2 Global Spine Biologics Market by Region: Market Forecast ($m), AGR(%), CAGR(%), 2014-2020
Table 7.3 Global Spine Biologics Market by Region: Market Forecast ($m), AGR(%), CAGR(%), 2020-2026
Table 7.4 North America Spine Biologics Market: Revenues ($m) and Market Share (%), 2015 and 2016
Table 7.5 North America Spine Biologics Market: Market Forecast ($m), AGR(%), CAGR(%), 2014-2020
Table 7.6 North America Spine Biologics Market: Market Forecast ($m), AGR(%), CAGR(%), 2020-2026
Table 7.7 Europe Spine Biologics Market: Revenues ($m) and Market Share (%), 2015 and 2016
Table 7.8 Europe Spine Biologics Market: Market Forecast ($m), AGR(%), CAGR(%), 2014-2020
Table 7.9 Europe Spine Biologics Market: Market Forecast ($m), AGR(%), CAGR(%), 2020-2026
Table 7.10 Asia-Pacific Spine Biologics Market: Revenues ($m) and Market Share (%), 2015 and 2016
Table 7.11 Asia-Pacific Spine Biologics Market: Market Forecast ($m), AGR(%), CAGR(%), 2014-2020
Table 7.12 Asia-Pacific Spine Biologics Market: Market Forecast ($m), AGR(%), CAGR(%), 2020-2026
Table 8.1 Medtronic ($m, 2011-2015)
Table 8.2 Medtronic plc: Revenue by Business Segment ($m), 2014-2015
Table 8.3 Medtronic plc: Revenue by Geographic Segment ($m), 2014-2015
Table 8.4 SeaSpine Holdings Corporation ($m, 2012-2015)
Table 8.5 SeaSpine Holdings Corporation: Revenue by Business Segment ($m), 2014-2015
Table 8.6 SeaSpine Holdings Corporation: Revenue by Geographic Segment ($m), 2014-2015
Table 8.7 JOHNSON & JOHNSON ($m, 2011-2015)
Table 8.8 JOHNSON & JOHNSON: Revenue by Business Segment ($m), 2014-2015
Table 8.9 JOHNSON & JOHNSON: Revenue by Geographic Segment ($m), 2014-2015
Table 8.10 Stryker Corporation ($m, 2011-2015)
Table 8.11 Stryker Corporation: Revenue by Business Segment, ($m, 2014-2015)
Table 8.12 Stryker Corporation: Revenue by Geographic Segment, ($m, 2014-2015)
Table 8.13 GLOBUS MEDICAL, INC. ($m, 2011-2015)
Table 8.14 GLOBUS MEDICAL, INC.: Revenue by Business Segment, ($m, 2014-2015)
Table 8.15 GLOBUS MEDICAL, INC.: Revenue by Geographic Segment, ($m, 2014-2015)
Table 8.16 ZIMMER BIOMET HOLDINGS, INC. ($m, 2013-2015)
Table 8.17 ZIMMER BIOMET HOLDINGS, INC.: Revenue by Business Segment ($m), 2014-2015
Table 8.18 ZIMMER BIOMET HOLDINGS, INC.: Revenue by Geographic Segment, ($m,2014-2015)
Table 8.19 NuVasive, Inc. ($m, 2013-2015)
Table 8.20 NuVasive, Inc.: Revenue by Business Segment, ($m,2014-2015)
Table 8.21 NuVasive, Inc.: Revenue by Geographic Segment, ($m,2014-2015)
Table 8.22 Alphatec Holdings, Inc.. ($m, 2011-2015)
Table 8.23 Alphatec Holdings, Inc.: Revenue by Geographic Segment, ($m,2014-2015)
Table 10.1 Global Spine Biologics: Market Forecast ($m, CAGR%), 2015, 2020 and 2026
Table 10.2 Global Spine Biologics Market by Type of Products : Revenues ($m) and Market Shares (%), 2015

List of Figures
Figure 1.1 Global Spine Biologics Market Segmentation
Figure 3.1 Global Spine Biologics Market Forecast ($m), AGR(%), 2015-2016
Figure 4.1 Spine Biologics Market Share (%) by Segment, 2020
Figure 4.2 Spine Biologics Market Share (%) by Segment, 2026
Figure 4.3 DBM Market Forecast: Revenue ($m) and AGR (%), 2015-2026
Figure 4.5 BMP/Growth Factors Market Forecast: Revenue ($m) and AGR (%), 2015-2026
Figure 4.6 Bone Substitutes Market Forecast: Revenue ($m) and AGR (%), 2015-2026
Figure 4.7 Cell Based Matrices Market Forecast: Revenue ($m) and AGR (%), 2015-2026
Figure 4.8 Machined Bone Market Forecast: Revenue ($m) and AGR (%), 2015-2026
Figure 4.9 Allograft Bone Market Forecast: Revenue ($m) and AGR (%), 2015-2026
Figure 4.10 Platelet Concentrators Market Forecast: Revenue ($m) and AGR (%), 2015-2026
Figure 4.11 Other Spine Biologics Market Forecast: Revenue ($m) and AGR (%), 2015-2026
Figure 5.1 Spine Biologics Market Share (%) by Segment, 2015
Figure 5.2 Spine Biologics Market Share (%) by Segment, 2020
Figure 5.3 Spine Biologics Market Share (%) by Segment, 2026
Figure 5.4 Traditional Fusion Market Forecast: Revenue ($m) and AGR (%), 2015-2026
Figure 5.5 Interbody Fusion Market Forecast: Revenue ($m) and AGR (%), 2015-2026
Figure 6.1 Spine Biologics Market Share (%)by Segment, 2015
Figure 6.2 Spine Biologics Market Share (%)by Segment, 2020
Figure 6.3 Spine Biologics Market Share (%)by Segment, 2026
Figure 6.4 Inpatient Surgery Spine Centers Market Forecast: Revenue ($m) and AGR (%), 2015-2026
Figure 6.5 Outpatient Surgery Spine Centers Market Forecast: Revenue ($m) and AGR (%), 2015-2026
Figure 7.1 Global Spine Biologics Market by Region: Market Size ($m), 2015 and 2016
Figure 7.2 US Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
Figure 7.3 Canada Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
Figure 7.4 Germany Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
Figure 7.5 UK Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
Figure 7.6 France Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
Figure 7.7 Italy Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
Figure 7.8 Spain Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
Figure 7.9 Russia Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
Figure 7.10 Rest of Europe Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
Figure 7.11 Asia Pacific Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
Figure 7.12 Japan Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
Figure 7.13 China Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
Figure 7.14 India Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
Figure 7.15 Australia Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
Figure 7.16 Rest of Asia-Pacific Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
Figure 7.17 RoW Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
Figure 8.1 Global Spine Biologics Market Share, By Companies (% share, 2015)
Figure 8.2 Medtronic plc: Historical sales and net income ($m), 2011-2015
Figure 8.3 Medtronic plc: Revenue Share by Business Area, (%, 2015)
Figure 8.4 Medtronic plc: Revenue Share by Geographic Segment (%, 2015)
Figure 8.5 SeaSpine Holdings Corporation: Historical sales and net income ($m), 2012-2015
Figure 8.6 SeaSpine Holdings Corporation: Revenue Share by Business Segment (%, 2015)
Figure 8.7 SeaSpine Holdings Corporation: Revenue Share by Geographic Segment (%, 2015)
Figure 8.8 JOHNSON & JOHNSON: Historical sales and net income, 2011-2015
Figure 8.9 JOHNSON & JOHNSON: Revenue Share by Business Segment (%, 2015)
Figure 8.10 JOHNSON & JOHNSON: Revenue Share by Geographic Segment (%, 2015)
Figure 8.11 Stryker Corporation: Historical sales and net income, 2011-2015
Figure 8.12 Stryker Corporation: Revenue Share by Business Segment, (%, 2015)
Figure 8.13 Stryker Corporation: Revenue Share by Geographic Segment (%, 2015)
Figure 8.14 GLOBUS MEDICAL, INC.: Historical sales and net income ($m), 2011-2015
Figure 8.15 GLOBUS MEDICAL, INC.: Revenue Share by Business Segment, (%, 2015)
Figure 8.16 GLOBUS MEDICAL, INC.: Revenue Share by Geographic Segment (%, 2015)
Figure 8.17 ZIMMER BIOMET HOLDINGS, INC.: Historical sales and net income ($m), 2013-2015
Figure 8.18 ZIMMER BIOMET HOLDINGS, INC.: Revenue Share by Business Segment, (%, 2015)
Figure 8.19 ZIMMER BIOMET HOLDINGS, INC.: Revenue Share by Geographic Segment (%, 2015)
Figure 8.20 NuVasive, Inc.: Historical sales and net income ($m), 2013-2015
Figure 8.21 NuVasive, Inc.: Revenue Share by Business Segment, (%, 2015)
Figure 8.22 NuVasive, Inc.: Revenue Share by Geographic Segment (%, 2015)
Figure 8.23 Alphatec Holdings, Inc.: Historical sales and net income ($m), 2011-2015
Figure 8.24 Alphatec Holdings, Inc.: Revenue Share by Geographic Segment (%, 2015)
Figure 10.1 Global Spine Biologics: Market Forecast ($m) 2015, 2020 and 2026
Figure 10.2 Global Spine Biologics Market by Type of Products: 2016 ($m)
Figure 10.3 Global Spine Biologics Market by Type of Products: 2026 ($m)
Figure 10.4 Global Spine Biologics Market by Geography: 2016 ($m)
Figure 10.5 Global Spine Biologics Market by Geography: 2026 ($m)

発刊日

2016/11/25

体裁

PDF / 142ページ

販売価格

1,999GBP

発行

Visiongain

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。
※シングルユーザーライセンスのレポートは印刷不可、およびライセンス期間は1年となります。
※印刷可能のレポートをご希望の場合は、デパートメントライセンス(ライセンス期間1年、ユーザー数5人)をご検討ください。
※詳しくはお問い合わせください。

関連カテゴリ

疾病別治療・領域別治療 / バイオ・ゲノム・再生医療

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE